The question
Which strategic partners could credibly support an ambitious preventive-health ecosystem, and what role should each organisation play in the wider model?
My role
I led the partner-evaluation workstream, assessing potential organisations against clinical capability, strategic fit, operating-model compatibility, willingness to participate, scalability and the role each could play within an integrated preventive-health ecosystem.
What mattered
The work focused on five questions:
-
Which capabilities were essential to make the ecosystem clinically credible and operationally viable?
-
Which potential partners possessed those capabilities at sufficient depth and scale?
-
How well did each organisation’s incentives, operating model and strategic priorities align with the intended programme?
-
Which roles could be integrated effectively across prevention, diagnosis, care delivery and ongoing health management?
-
Where would partnerships create genuine system-level value rather than simply add another standalone service provider?
The evaluation therefore started with the capabilities required by the target model, rather than with a list of well-known institutions.
Potential partners were then assessed on the specific contribution they could make to the ecosystem, including clinical expertise, delivery capability, scalability, strategic commitment and the practicality of working within a coordinated operating model.
The broader lesson
Partnership strategy is strongest when it begins with the capabilities an ecosystem needs rather than the prominence of potential partners.
The right partner is not necessarily the most recognised institution. It is the organisation whose capabilities, incentives, operating contribution and willingness to collaborate fit the intended model.
In complex healthcare ecosystems, partner quality depends as much on role clarity and alignment as on institutional capability.